Search - tctmd.com

Displaying 961 - 980 of 3013

Sort: Relevancy | Date

Presentation TCT 2019

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Presenter: Fazila Malik

September 27, 2019

Presentation TCT 2019

Treating Challenging SFA Disease in the Era of Paclitaxel Uncertainty

Presenter: Aravinda Nanjundappa

September 27, 2019

Presentation TCT 2019

Provisional Stenting Remains the Reference and Preserves My Options!

Presenter: Goran Stankovic

September 26, 2019

Presentation TCT 2019

An Optimized, Upfront Two-Stent Strategy (a.k.a. DK Crush) Is My New Standard!

Presenter: James Hermiller

September 26, 2019

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Using Dedicated Bifurcation Stents in Clinical Practice

Presenter: Carlo Briguori

September 26, 2019

Presentation TCT 2019

IVUS/OCT Guidance of Non-LM Bifurcation Stenting: When and How to Use it in Practice

Presenter: Yoshinobu Onuma

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

Presentation TCT 2019

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Presenter: Ken Kozuma

September 26, 2019

Presentation TCT 2019

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Presenter: Ajay Kirtane

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

Presentation TCT 2019

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

Presenter: Stephan Windecker

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going?

Presenter: Robert Byrne

September 26, 2019

Presentation TCT 2019

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Primer on Metallic Stents Developed in India

Presenter: Upendra Kaul

September 26, 2019

Presentation TCT 2019

Restoring Damaged Arteries With Regenerative Stents (STENTiT)

Presenter: Mari Sol Cabrera

September 26, 2019

Advertisement

Does Stent Design Make a Difference in Treating LM Bifurcation Lesions?

Treating Challenging SFA Disease in the Era of Paclitaxel Uncertainty

Provisional Stenting Remains the Reference and Preserves My Options!

An Optimized, Upfront Two-Stent Strategy (a.k.a. DK Crush) Is My New Standard!

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Using Dedicated Bifurcation Stents in Clinical Practice

IVUS/OCT Guidance of Non-LM Bifurcation Stenting: When and How to Use it in Practice

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Onyx ONE: A Randomized Trial of a Durable-Polymer Drug-Eluting Stent vs. a Polymer-Free Drug-Coated Stent in Patients at High Risk of Bleeding Treated With 1-Month DAPT

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Short and Ultrashort DAPT Strategies After Stent Implantation: What Do We Know and Where Are We Going?

The Low-Bleeding Risk Patient: Should DAPT be Tailored Based on Clinical Presentation, Anatomic Complexity or DES Type?

The High-Bleeding Risk Patient: Current Recommendations and Overview of Dedicated Trials

Primer on Metallic Stents Developed in India

Restoring Damaged Arteries With Regenerative Stents (STENTiT)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content